INJ Price Prediction: Targeting $4.84 Recovery by Year-End Despite Bearish Momentum

INJ Price Prediction Summary

• INJ short-term target (1 week): $4.84 (+8.0% from current $4.48) • Injective medium-term forecast (1 month): $4.70-$4.93 trading range • Key level to break for bullish continuation: $4.93 (upper Bollinger Band resistance) • Critical support if bearish: $4.35 (strong support confluence)

Recent Injective Price Predictions from Analysts

Multiple analysts converge on a cautious but optimistic INJ price prediction for the remainder of December 2025. CoinCodex and MEXC News both project an Injective forecast targeting $4.84 by December 26, representing an 8% recovery from current levels.

The consensus among analysts centers on the critical $4.72 support level, which has held firm despite recent selling pressure. This INJ price target of $4.84 aligns with technical resistance levels and suggests a modest recovery scenario rather than aggressive bullish momentum.

Notably, all recent predictions maintain medium confidence levels, indicating uncertainty in the current market environment. The projected December average of $4.83 suggests sideways consolidation rather than trending behavior, reflecting the challenging technical setup facing Injective.

INJ Technical Analysis: Setting Up for Consolidation

Injective technical analysis reveals a mixed picture with bearish momentum indicators conflicting with oversold conditions. The current RSI reading of 34.38 sits in neutral territory but closer to oversold levels, typically a precursor to short-term bounces.

The MACD histogram at -0.0034 confirms bearish momentum, though the minimal negative reading suggests weakening selling pressure. More significantly, INJ's position at 0.15 within the Bollinger Bands indicates the price is trading near the lower band at $4.21, historically a zone where bounces occur.

Volume analysis from Binance spot markets shows $4.66 million in 24-hour trading, which is moderate but sufficient to support the predicted recovery move. The daily ATR of $0.41 suggests that the $4.84 target represents approximately two standard deviations of recent volatility, making it a reasonable near-term objective.

Injective Price Targets: Bull and Bear Scenarios

Bullish Case for INJ

The primary bullish scenario for this INJ price prediction targets the $4.84 resistance level, with potential extension to $4.93 if momentum builds. Breaking above the EMA 12 at $4.81 would confirm the recovery narrative and open the path to these higher targets.

For sustained upside, INJ needs to reclaim the SMA 7 at $4.62 first, followed by a decisive break above $4.84. Success here could lead to a test of the SMA 20 at $5.09, representing a 14% gain from current levels.

The Stochastic indicators at extremely low levels (%K: 8.95) support the bounce thesis, as these readings historically precede short-term reversals in Injective's price action.

Bearish Risk for Injective

The Injective forecast faces significant downside risks if the $4.35 support level fails. This level represents both immediate and strong support confluence, making it critical for maintaining the consolidation scenario.

A break below $4.35 could trigger a retest of the 52-week low at $4.43, with potential extension toward the lower Bollinger Band at $4.21. Such a scenario would invalidate the current recovery prediction and suggest deeper correction ahead.

The bearish momentum reflected in the MACD setup remains the primary risk factor, particularly if accompanied by increasing selling volume.

Should You Buy INJ Now? Entry Strategy

Current levels present a reasonable buy or sell INJ opportunity for traders seeking short-term gains. The optimal entry strategy involves accumulating near current support at $4.48, with additional buying if INJ tests the $4.35 strong support level.

Risk management requires a stop-loss below $4.21 (lower Bollinger Band) to protect against breakdown scenarios. Position sizing should account for the 5% risk from current levels to the stop-loss point.

For conservative investors, waiting for a break above $4.62 (SMA 7) would provide better confirmation of the recovery narrative, though at the cost of missing the initial move.

INJ Price Prediction Conclusion

The INJ price prediction for the remainder of December 2025 targets $4.84 with medium confidence, supported by oversold technical conditions and analyst consensus. The Injective forecast suggests a 7-10 day timeframe for this recovery to materialize.

Key confirmation signals include RSI moving above 40, MACD histogram turning positive, and volume expansion above 6 million daily. Invalidation occurs on a break below $4.35 with sustained bearish momentum.

This INJ price target represents a tactical bounce within a broader consolidation pattern, making it suitable for short-term trading rather than long-term investment positioning. Monitor the $4.72 support level closely as the critical determinant for the prediction's success.